Cargando…
Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
Autores principales: | Jurado, C, Bader-Meunier, B, Ranchin, B, Decramer, S, Fischbac, M, Bérard, E, Saint-Marcoux, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194611/ http://dx.doi.org/10.1186/1546-0096-9-S1-P248 |
Ejemplares similares
-
PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
por: Woillard, JB, et al.
Publicado: (2013) -
Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008) -
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010) -
Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008) -
Pediatric systemic lupus erythematosus and human parvovirus B19 infection
por: Bélien-Pallet, V, et al.
Publicado: (2011)